| 1 | The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII | 5.3 | 30 | Citations (PDF) |
| 2 | Calixarenes Incorporating Sulfonamide Moieties: Versatile Ligands for Carbonic Anhydrases Inhibition | 3.5 | 5 | Citations (PDF) |
| 3 | Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores | 4.2 | 13 | Citations (PDF) |
| 4 | Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors | 4.2 | 15 | Citations (PDF) |
| 5 | Discovery of Potent Carbonic Anhydrase Inhibitors as Effective Anticonvulsant Agents: Drug Design, Synthesis, and In Vitro and In Vivo Investigations | 6.9 | 20 | Citations (PDF) |
| 6 | Benzyl alcohol inhibits carbonic anhydrases by anchoring to the zinc coordinated water molecule | 2.1 | 10 | Citations (PDF) |
| 7 | Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides | 5.5 | 36 | Citations (PDF) |
| 8 | Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides | 4.2 | 16 | Citations (PDF) |
| 9 | Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy | 3.5 | 5 | Citations (PDF) |
| 10 | Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors | 5.5 | 49 | Citations (PDF) |
| 11 | Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug–Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis | 6.9 | 29 | Citations (PDF) |
| 12 | Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII | 4.2 | 19 | Citations (PDF) |
| 13 | Pyrrolo and pyrrolopyrimidine sulfonamides act as cytotoxic agents in hypoxia via inhibition of transmembrane carbonic anhydrases | 5.5 | 25 | Citations (PDF) |
| 14 | “A Sweet Combination”: Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII | 6.9 | 28 | Citations (PDF) |
| 15 | Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases | 5.3 | 13 | Citations (PDF) |
| 16 | Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity | 5.5 | 16 | Citations (PDF) |
| 17 | Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action | 6.9 | 85 | Citations (PDF) |
| 18 | S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors | 5.3 | 22 | Citations (PDF) |
| 19 | Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action | 6.9 | 36 | Citations (PDF) |
| 20 | Synthesis of some N-aroyl-2-oxindole benzenesulfonamide conjugates with carbonic anhydrase inhibitory activity | 4.2 | 17 | Citations (PDF) |
| 21 | Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells | 4.4 | 31 | Citations (PDF) |
| 22 | Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells | 5.5 | 40 | Citations (PDF) |
| 23 | Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors | 5.3 | 24 | Citations (PDF) |
| 24 | Carbonic anhydrase inhibitors as diuretics 2019, , 287-309 | | 4 | Citations (PDF) |
| 25 | New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment | 5.5 | 15 | Citations (PDF) |
| 26 | Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors | 4.2 | 15 | Citations (PDF) |
| 27 | Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity | 4.2 | 23 | Citations (PDF) |
| 28 | 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights | 5.5 | 61 | Citations (PDF) |
| 29 | Extending the Inhibition Profiles of Coumarin-Based Compounds Against Human Carbonic Anhydrases: Synthesis, Biological, and In Silico Evaluation | 4.4 | 8 | Citations (PDF) |
| 30 | Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex | 4.2 | 21 | Citations (PDF) |
| 31 | Synthesis and comparative carbonic anhydrase inhibition of new Schiff’s bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds | 4.2 | 18 | Citations (PDF) |
| 32 | Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors | 4.2 | 37 | Citations (PDF) |
| 33 | Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies | 5.3 | 29 | Citations (PDF) |
| 34 | Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors | 5.5 | 41 | Citations (PDF) |
| 35 | Diagnostic markers for glaucoma: a patent and literature review (2013-2019) | 4.1 | 21 | Citations (PDF) |
| 36 | α-Carbonic anhydrases are strongly activated by spinaceamine derivatives | 2.7 | 25 | Citations (PDF) |
| 37 | Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae | 4.2 | 19 | Citations (PDF) |
| 38 | Benzenesulfonamides incorporating nitrogenous bases show effective inhibition of β-carbonic anhydrases from the pathogenic fungi Cryptococcus neoformans, Candida glabrata and Malassezia globosa | 4.2 | 12 | Citations (PDF) |
| 39 | Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights | 4.5 | 23 | Citations (PDF) |
| 40 | Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives | 5.3 | 23 | Citations (PDF) |
| 41 | Indole-Based Hydrazones Containing A Sulfonamide Moiety as Selective Inhibitors of Tumor-Associated Human Carbonic Anhydrase Isoforms IX and XII | 4.5 | 23 | Citations (PDF) |
| 42 | Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives | 4.2 | 34 | Citations (PDF) |
| 43 | Comparison of the Sulfonamide Inhibition Profiles of the α-Carbonic Anhydrase Isoforms (SpiCA1, SpiCA2 and SpiCA3) Encoded by the Genome of the Scleractinian Coral Stylophora pistillata | 5.3 | 5 | Citations (PDF) |
| 44 | Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII | 4.5 | 26 | Citations (PDF) |
| 45 | Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies | 4.2 | 48 | Citations (PDF) |
| 46 | Activation Studies of the β-Carbonic Anhydrase from the Pathogenic Protozoan Entamoeba histolytica with Amino Acids and Amines | 3.5 | 10 | Citations (PDF) |
| 47 | Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors | 2.7 | 53 | Citations (PDF) |
| 48 | Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors | 4.2 | 40 | Citations (PDF) |
| 49 | Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents | 5.5 | 83 | Citations (PDF) |
| 50 | 3-Aminobenzenesulfonamides incorporating acylthiourea moieties selectively inhibit the tumor-associated carbonic anhydrase isoform IX over the off-target isoforms I, II and IV | 4.2 | 9 | Citations (PDF) |
| 51 | Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors | 4.2 | 46 | Citations (PDF) |
| 52 | Synthesis, structure and bioactivity of primary sulfamate-containing natural products | 2.1 | 17 | Citations (PDF) |
| 53 | Natural Polyphenols Selectively Inhibit β‐Carbonic Anhydrase from the Dandruff‐Producing Fungus <i>Malassezia globosa</i>: Activity and Modeling Studies | 3.2 | 34 | Citations (PDF) |
| 54 | 2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents | 5.5 | 35 | Citations (PDF) |
| 55 | Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors | 4.2 | 52 | Citations (PDF) |
| 56 | Synthesis and biological evaluation of novel N,N′-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors | 4.2 | 34 | Citations (PDF) |
| 57 | Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes | 4.2 | 44 | Citations (PDF) |
| 58 | Inhibition studies on a panel of human carbonic anhydrases with<i>N</i>1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails | 5.3 | 41 | Citations (PDF) |
| 59 | Mono- and di-thiocarbamate inhibition studies of the δ-carbonic anhydrase TweCAδ from the marine diatom<i>Thalassiosira weissflogii</i> | 5.3 | 18 | Citations (PDF) |
| 60 | Discovery of Benzenesulfonamide Derivatives as Carbonic Anhydrase Inhibitors with Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Evaluation | 6.9 | 29 | Citations (PDF) |
| 61 | Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry | 5.3 | 22 | Citations (PDF) |
| 62 | Improving the carbonic anhydrase inhibition profile of the sulfamoylphenyl pharmacophore by attachment of carbohydrate moieties | 4.2 | 11 | Citations (PDF) |
| 63 | Sulfonamide Inhibition Studies of a New β-Carbonic Anhydrase from the Pathogenic Protozoan Entamoeba histolytica | 4.5 | 14 | Citations (PDF) |
| 64 | Cloning, Characterization and Anion Inhibition Studies of a β-Carbonic Anhydrase from the Pathogenic Protozoan Entamoeba histolytica | 4.4 | 15 | Citations (PDF) |
| 65 | Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors | 5.3 | 44 | Citations (PDF) |
| 66 | Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and<i>Mycobacterium tuberculosis</i><b>β</b>-class enzyme Rv3273 | 5.3 | 30 | Citations (PDF) |
| 67 | Discovery of β-Adrenergic Receptors Blocker–Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy | 6.9 | 52 | Citations (PDF) |
| 68 | Comparison of the Anion Inhibition Profiles of the α-CA Isoforms (SpiCA1, SpiCA2 and SpiCA3) from the Scleractinian Coral Stylophora pistillata | 4.5 | 10 | Citations (PDF) |
| 69 | Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies | 5.5 | 54 | Citations (PDF) |
| 70 | Synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes | 5.3 | 8 | Citations (PDF) |
| 71 | Novel 6- and 7-Substituted Coumarins with Inhibitory Action against Lipoxygenase and Tumor-Associated Carbonic Anhydrase IX | 4.4 | 32 | Citations (PDF) |
| 72 | Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal | 5.5 | 24 | Citations (PDF) |
| 73 | Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and<i>Vibrio cholerae</i>α- and β-class enzymes | 5.3 | 15 | Citations (PDF) |
| 74 | Synthesis of novel dipeptide sulfonamide conjugates with effective carbonic anhydrase I, II, IX, and XII inhibitory properties | 4.2 | 20 | Citations (PDF) |
| 75 | Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX | 4.2 | 18 | Citations (PDF) |
| 76 | Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors | 5.5 | 52 | Citations (PDF) |
| 77 | Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies | 5.5 | 58 | Citations (PDF) |
| 78 | Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis | 6.9 | 110 | Citations (PDF) |
| 79 | Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data | 3.1 | 15 | Citations (PDF) |
| 80 | Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties | 2.7 | 29 | Citations (PDF) |
| 81 | Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium | 5.3 | 20 | Citations (PDF) |
| 82 | Inhibition of Malassezia globosa carbonic anhydrase with phenols | 2.7 | 42 | Citations (PDF) |
| 83 | Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors | 2.7 | 39 | Citations (PDF) |
| 84 | Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity | 5.3 | 43 | Citations (PDF) |
| 85 | Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases | 3.6 | 65 | Citations (PDF) |
| 86 | Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives | 5.3 | 13 | Citations (PDF) |
| 87 | Novel Sulfamide-Containing Compounds as Selective Carbonic Anhydrase I Inhibitors | 4.4 | 25 | Citations (PDF) |
| 88 | Synthesis and carbonic anhydrase inhibitory effects of new N-glycosylsulfonamides incorporating the phenol moiety | 2.1 | 9 | Citations (PDF) |
